Claims do more than describe a product — they can influence how a product is classified.

This session will examine how cosmetic marketing language can push a product toward borderline status when claims imply treatment, prevention, physiological effect, or medicinal benefit. Through practical examples, the session will explore common claim areas that raise regulatory concerns, where the line sits between cosmetic, medical device, and medicinal positioning, and how teams can identify risk before communication goes live.

Attendees will leave with practical guidance on how to review claim wording, avoid unintended regulatory status risk, and keep product communication clear, compliant, and defensible.